This inventor holds 6 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: European Molecular Biology Laboratory, The Rockefeller University, Mtm Laboratories, Ag. Active years: 2000-2026.
Company Filing History:
2 out of 79 
2 out of 751 
1 out of 12 Years Active: 2000-2026
Title: Peer Bork: Innovator in Microbiome and Cancer Research
Introduction
Peer Bork is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the fields of microbiome research and cancer treatment. With a total of 6 patents, his work focuses on innovative approaches to combat infections and improve therapeutic strategies.
Latest Patents
Bork's latest patents include groundbreaking inventions related to repurposing compounds for the treatment of infections and modulating the gut microbiome. One of his notable inventions involves agents and compositions that modify the growth of bacterial cells. These compounds are designed for the prevention and treatment of various diseases, including infectious diseases, gastrointestinal disorders, and metabolic disorders. His research emphasizes the development of narrow-spectrum antibacterial therapies, which aim to reduce the side effects associated with traditional antibacterial treatments. Additionally, he has developed compounds and methods for the detection and treatment of cancers associated with frameshift mutations, particularly in DNA mismatch repair deficient tumors.
Career Highlights
Throughout his career, Peer Bork has worked with several notable companies, including Mtm Laboratories and Roche. His expertise in microbiome research and cancer treatment has positioned him as a leader in his field. Bork's innovative approaches have the potential to revolutionize treatment strategies and improve patient outcomes.
Collaborations
Peer Bork has collaborated with esteemed colleagues such as Magnus Von Knebel-Doeberitz and Johannes Gebert. These partnerships have further enhanced his research and contributed to the advancement of medical science.
Conclusion
Peer Bork's contributions to microbiome research and cancer treatment exemplify the impact of innovation in healthcare. His patents and collaborative efforts continue to pave the way for new therapeutic strategies that address complex medical challenges.